[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@doepke_michel Michel Doepke

Michel Doepke posts on X about $ptgx, $jnj, $idya, $bayn the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

X Week XXXXXX -XX%
X Month XXXXXXX -XX%
X Months XXXXXXXXX +68%
X Year XXXXXXXXX +144%

Mentions: XX #

X Week XXX -XX%
X Month XXX -XX%
X Months XXXXX +45%
X Year XXXXX +152%

Followers: XXXXX #

X Week XXXXX +0.70%
X Month XXXXX +3.10%
X Months XXXXX +26%
X Year XXXXX +50%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXXX% finance XXXX% cryptocurrencies XXXX% countries XXXX% currencies XXXX% travel destinations XXXX%

Social topic influence $ptgx #2, $jnj #5, $idya 4.76%, $bayn 4.17%, $crnx #7, $sny #5, $lly #23, market cap #815, $regn #5, $tak #3

Top accounts mentioned or mentioned by @aggregategains @biohazard3737 @bionavgator @midwit_capital @semodough @amaymd @damiangarde @persimmonti @protagonisttxs @aktionaer @reddit @biopharmiq @valuedig @biotechvantage @maximizebelief2 @macrovet888 @meadowcapital @mugsley @sanityninsanity @phoenicianstrat

Top Social Posts

Top posts by engagements in the last XX hours

"$HALO Provides Update on Non-Binding Proposal to Combine with Evotec. $EVT"
X Link 2024-11-18T12:18Z 5927 followers, 1050 engagements

"After $EVT M&A attempt: $HALO to Acquire Elektrofi Expanding Our Offerings in Innovative Drug Delivery and Strengthening Long-Term Growth into 2040s"
X Link 2025-10-01T11:06Z 5927 followers, 1769 engagements

"$TSHA Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome. #Astellas"
X Link 2025-10-16T20:03Z 5926 followers, 11.9K engagements

"$IDYA great lead asset and more to come. Still too cheap imho. #ESMO25"
X Link 2025-10-18T21:43Z 5924 followers, 3442 engagements

"$IDYA Announces Positive Phase X Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025"
X Link 2025-10-20T10:32Z 5923 followers, 1167 engagements

"$TAK Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors"
X Link 2025-10-22T05:10Z 5928 followers, 1963 engagements

"$SMMT $500M PIPE @ $18.74$ per share. $AZN Summit Co-CEO and Executive Chairman Robert Duggan Co-CEO and President Mahkam Zanganeh CFO and COO Manmeet Soni CAO Bhaskar Anand and certain non-executive employees invested $272M; Akeso invested $10M remaining $218M raised with multiple leading biopharma institutional investors and other institutional investors"
X Link 2025-10-22T12:24Z 5929 followers, 9023 engagements

"$LLY to acquire $ADVM - $XXXX per share + $XXXX per CVR"
X Link 2025-10-24T12:33Z 5924 followers, 6144 engagements

"$IDYA 52-week high"
X Link 2025-10-28T13:43Z 5923 followers, 4487 engagements

"$NBIX Reports Third Quarter 2025 Financial Results. CRENESSITY (crinecerfont) Third-Quarter 2025 Net Product Sales of $98M"
X Link 2025-10-28T20:10Z 5926 followers, 1210 engagements

"$IDYA despite 52-week high just $2.9B market cap. $992M cash at the end of June + $210M upfront payment from Servier. Financed over several years. Multiple shots on goal - I wouldn't be surprised if $IDYA trades above $XXX in the long term"
X Link 2025-10-29T10:25Z 5923 followers, 2480 engagements

"$KYTX nnounces Positive Interim Phase X Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025. $ARGX $JNJ"
X Link 2025-10-29T10:33Z 5925 followers, 1059 engagements

"$PTGX strong finish yesterday into close. The company knows how valuable the asset Icotrokinra is and what potential the early stage programs have. Protagonist will not and does not want to sell itself below value. I think that patience will pay off here. $JNJ $TAK"
X Link 2025-10-29T11:47Z 5923 followers, 2827 engagements

"$SMMT Overall Survival Data from HARMONi-A Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China to be Showcased at SITC 2025. $PFE $BNTX $BMY"
X Link 2025-10-31T11:02Z 5926 followers, 1233 engagements

"$BMY removes X clinical programs from pipeline one from $MRTX and another from $EXAI/ $RXRX"
X Link 2025-11-01T12:43Z 5927 followers, 5199 engagements

"$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer"
X Link 2025-11-03T06:21Z 5926 followers, 1975 engagements

"$IDYA Reports Third Quarter 2025 Financial Results and Provides Business Update. $1.14B cash"
X Link 2025-11-04T11:05Z 5923 followers, XXX engagements

"$RYTM Announces Public Reimbursement for IMCIVREE (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program"
X Link 2025-11-05T21:03Z 5925 followers, XXX engagements

"$ONC Q3 results. Third quarter total revenues increased XX% to $1.4B"
X Link 2025-11-06T11:03Z 5925 followers, 1062 engagements

"An approval for Povetacicept (formerly ALPN-303) would also be a success for German based #Evotec. They have a multi-year partnership with $ALPN which was acquired by $VRTX for $4.9B in 2024"
X Link 2025-11-09T11:45Z 5926 followers, 3975 engagements

"$IFRX Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU). $UCB $MLTX $CLDX"
X Link 2025-11-10T12:32Z 5924 followers, 1555 engagements

"$RLMD should receive more attention here. Small position. $ENGN $CGON"
X Link 2025-11-11T14:58Z 5928 followers, 7706 engagements

"The year of liver diseases $ETNB and $AKRO gone. $MDGL new ATH $12B valuation. 😎👍"
X Link 2025-11-11T16:12Z 5922 followers, 5248 engagements

"$EVT #Evotecreceives milestone payment from $BMY Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership. $5M to Evotec"
X Link 2025-11-12T06:43Z 5926 followers, 1254 engagements

"$BAYN #Bayer significant gains for Nubeqa and Kerendia but business headwinds mainly related to declines for Xarelto due to patent expirations as well as lower Eylea sales. #Orion $REGN"
X Link 2025-11-12T06:48Z 5925 followers, 1701 engagements

"$BAYN #Bayer The glyphosate case is and remains a never-ending story at Bayer. Provisions for legal costs are being increased again. Compared to the previous year there are now 2000 more lawsuits pending. $MON"
X Link 2025-11-12T06:54Z 5925 followers, 1688 engagements

"$LEGN Q3 results. Carvykti net trade sales of approximately $524M. $JNJ"
X Link 2025-11-12T12:04Z 5922 followers, XXX engagements

"$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)"
X Link 2025-11-12T15:32Z 5928 followers, 3887 engagements

"$DAWN to Acquire $MRSN - $XX per share + CVR"
X Link 2025-11-13T12:59Z 5929 followers, 1170 engagements

"Long $CRNX and $PTGX 👍"
X Link 2025-11-13T14:29Z 5922 followers, 2982 engagements

"Next bidding war M&A in the biotech space is heating up $AVDL Board of Directors Determines Proposal From #Lundbeck Reasonably Expected to Result in a Company Superior Proposal. $ALKS"
X Link 2025-11-14T10:53Z 5926 followers, 8226 engagements

"$IONS DAWNZERA (donidalorsen) receives positive opinion from CHMP recommended for approval in EU for hereditary angioedema (HAE)"
X Link 2025-11-14T12:02Z 5927 followers, XXX engagements

"Upcoming $PHVS deucrictibant data also important for $RPRX and German based #BRAINBiotech"
X Link 2025-11-17T10:54Z 5926 followers, 1887 engagements

"$AVDL Board of Directors Declares Lundbeck Proposal a Company Superior Proposal. . $ALKS"
X Link 2025-11-17T10:55Z 5926 followers, 1268 engagements

"$MRUS and $HALO Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab"
X Link 2025-11-17T12:40Z 5925 followers, 1686 engagements

"$CRNX looking good"
X Link 2025-11-17T17:03Z 5926 followers, 1323 engagements

"$VSTM $MCRB"
X Link 2025-11-17T20:31Z 5924 followers, 1687 engagements

"$CELC Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer"
X Link 2025-11-17T21:07Z 5922 followers, 1504 engagements

"$PTGX $JNJ $TAK"
X Link 2025-11-18T12:56Z 5922 followers, 3700 engagements

"$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B"
X Link 2025-11-18T15:25Z 5928 followers, 131.2K engagements

"$ALKS Announces Increased Offer to Acquire $AVDL - for total transaction consideration of up to $XXXXX per share #BiddingWar #Lundbeck"
X Link 2025-11-19T11:01Z 5926 followers, 1464 engagements

"$BAYN #Bayer FDA grants accelerated approval to Bayers HYRNUO (sevabertinib) for patients with previously treated advanced HER2-mutant non-small cell lung cancer"
X Link 2025-11-20T07:36Z 5925 followers, 1600 engagements

"What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available"
X Link 2025-11-20T14:01Z 5922 followers, 8599 engagements

"$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome"
X Link 2025-11-21T06:59Z 5926 followers, 1313 engagements

"$GEHC to acquire Intelerad advancing cloud-enabled enterprise imaging across care settings for $2.3B. #Sectra $SECTRA"
X Link 2025-11-21T07:56Z 5926 followers, 1236 engagements

"$BAYN #Bayer Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention. $BMY $JNJ"
X Link 2025-11-23T17:33Z 5925 followers, 2936 engagements

"$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX"
X Link 2025-11-25T06:46Z 5925 followers, 12.2K engagements

"From injections to pills: oral peptides set to transform drug development (August 2025). $PTGX $JNJ $MRK"
X Link 2025-11-27T09:33Z 5928 followers, 4059 engagements

"$PTGX TD Cowen Advancements in #Obesity Summit. Some interesting comments. $LLY $NVO"
X Link 2025-11-27T15:01Z 5922 followers, 3323 engagements

"#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST"
X Link 2025-11-28T07:08Z 5926 followers, 1870 engagements

"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY"
X Link 2025-11-30T09:16Z 5925 followers, 9553 engagements

"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 2) 👇 $SNY $REGN $AMGN @aktionaer"
X Link 2025-11-30T09:53Z 5929 followers, 4639 engagements

"$IDYA Announces IND Clearance for IDE034 a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types"
X Link 2025-12-01T11:41Z 5922 followers, 2305 engagements

"$IONS receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG)"
X Link 2025-12-01T12:01Z 5927 followers, 1808 engagements

"$BAYN #Bayer welcomes Solicitor General support for U.S. Supreme Court review. Shares up 9%"
X Link 2025-12-02T06:49Z 5925 followers, 1383 engagements

"$VTYX Provides Clinical and Corporate Updates"
X Link 2025-12-02T12:03Z 5924 followers, 1538 engagements

"$IONS receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)"
X Link 2025-12-02T12:05Z 5927 followers, 1034 engagements

"$SGMO Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy"
X Link 2025-12-02T13:11Z 5923 followers, 2260 engagements

"$CLDX strength up X% after $JSPR asthma data"
X Link 2025-12-02T17:09Z 5924 followers, 2193 engagements

"$CAPR Announces Positive Topline Results from Pivotal Phase X HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy. $SRPT"
X Link 2025-12-03T12:36Z 5928 followers, 2663 engagements

"$CRNX next step 👍"
X Link 2025-12-03T13:11Z 5924 followers, 2281 engagements

"$CRNX break. Next target $60"
X Link 2025-12-03T15:22Z 5926 followers, 1981 engagements

"Interesting. $ABBV already partnered with $GUBRA (amylin) this year. Who's next $LLY $NVO $VKTX $GPCR"
X Link 2025-12-03T16:44Z 5927 followers, 7140 engagements

"Influential study on #glyphosate safety retracted XX years after publication - "several critical issues that are considered to undermine the academic integrity of this article and its conclusions." $MON $BAYN #Bayer #Glyphosat"
X Link 2025-12-04T07:47Z 5925 followers, 1007 engagements

"$PODD Announces FDA 510(k) Clearance of Omnipod X Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience. $TNDM"
X Link 2025-12-04T12:01Z 5926 followers, 1030 engagements

"$DNLI and $RPRX Announce $XXX Million Royalty Funding Agreement"
X Link 2025-12-04T12:02Z 5927 followers, 4462 engagements

"$HALO Wins Preliminary Injunction Against Merck's Keytruda SC in Germany. $MRK"
X Link 2025-12-04T18:33Z 5927 followers, 2424 engagements

"IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance"
X Link 2025-12-05T07:09Z 5923 followers, 1203 engagements

"$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones"
X Link 2025-12-05T12:08Z 5923 followers, 1706 engagements

"$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position"
X Link 2025-12-05T12:38Z 5924 followers, XXX engagements

"The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit"
X Link 2025-12-05T13:45Z 5926 followers, 1893 engagements

"$PTGX strength into the weekend. Deal close $JNJ $TAK"
X Link 2025-12-05T20:00Z 5922 followers, 2875 engagements

"$GSK GSK terminates collaboration agreement with $IDYA"
X Link 2025-12-06T06:56Z 5922 followers, 8536 engagements

"$PTGX and $TAK Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera"
X Link 2025-12-06T17:56Z 5926 followers, 1482 engagements

"$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)"
X Link 2025-12-06T17:57Z 5926 followers, 2414 engagements

"$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY"
X Link 2025-12-06T18:00Z 5927 followers, 8617 engagements

"OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. $ABBV"
X Link 2025-12-08T06:35Z 5926 followers, 1408 engagements

"$GLPG Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025"
X Link 2025-12-08T06:35Z 5926 followers, XXX engagements

"Wow: LORAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN #GALDERMA WITH AN ADDITIONAL XX% BRINGING ITS TOTAL PARTICIPATION TO 20%"
X Link 2025-12-08T06:36Z 5925 followers, 3159 engagements

"$UCB presents positive results from GEMZ phase X study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder"
X Link 2025-12-08T06:37Z 5926 followers, 1650 engagements

"$GUBRA #BoehringerIngelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development. $LLY $NVO $VKTX $ABBV"
X Link 2025-12-08T07:05Z 5926 followers, 1383 engagements

"$GPCR $WVE $KYMR and $DYN data ahead - busy #biotech Monday. Maybe also a M&A deal $PTGX $RVMD $ABVX"
X Link 2025-12-08T07:52Z 5927 followers, 7951 engagements

"$PTGX early stage program but PN-881 could have gamechanger potential. It's incredible how strongly $UCB is growing with Bimzelx. A multi-billion dollar opportunity - and $JNJ may be aware of this potential. Maybe we get a PR tomorrow - $JNJ to report Q3 results on Tuesday. $NVS"
X Link 2025-10-12T18:25Z 5928 followers, 7189 engagements

"#Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse. Transaction includes $350M in cash and upfront license fees. JEB partnered projects below. $SDZ $EVT"
X Link 2025-11-05T07:00Z 5928 followers, 1135 engagements

"$CAI Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance"
X Link 2025-11-05T21:06Z 5928 followers, 1259 engagements

"$PTGX PN-881 entered the clinical stage. First human subject dosed in a Phase X trial in October"
X Link 2025-11-07T10:07Z 5928 followers, 3347 engagements

"$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX"
X Link 2025-11-07T10:16Z 5928 followers, 9039 engagements

"$RHHBY fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis. $TGTX"
X Link 2025-11-10T06:02Z 5928 followers, 4889 engagements

"$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH"
X Link 2025-11-10T12:01Z 5928 followers, 17.4K engagements

"$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME"
X Link 2025-11-17T11:03Z 5928 followers, 3306 engagements

"$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS"
X Link 2025-12-01T06:53Z 5928 followers, 5038 engagements

"$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN"
X Link 2025-12-01T06:53Z 5928 followers, 8460 engagements

"$REGN and Tessera Therapeutics to Jointly Develop TSRA-196 an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (#AATD)"
X Link 2025-12-01T12:01Z 5928 followers, 1325 engagements

"$AZN #Astrazeneca Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension. PDUFA date is anticipated during the second quarter of 2026 following use of a Priority Review voucher. $MLYS"
X Link 2025-12-02T08:09Z 5928 followers, 1529 engagements

"$BAYN #Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia"
X Link 2025-12-02T13:44Z 5928 followers, XXX engagements

"$PHVS $RPRX"
X Link 2025-12-03T11:57Z 5928 followers, 1806 engagements

"After $JNJ and $NVO failures: $BMY Announces Continuation of ADEPT-2 Phase X Study in Psychosis Associated with Alzheimer's Disease"
X Link 2025-12-03T12:08Z 5928 followers, 4256 engagements

"Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR"
X Link 2025-12-04T09:38Z 5928 followers, 7711 engagements

"What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA"
X Link 2025-12-04T14:48Z 5928 followers, 2892 engagements

"$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT"
X Link 2025-12-05T13:06Z 5928 followers, 4431 engagements

"$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS"
X Link 2025-12-05T13:53Z 5928 followers, 2340 engagements

"$ZLAB Announces Updates to Chinas National Reimbursement Drug List"
X Link 2025-12-07T09:57Z 5928 followers, 1588 engagements

"Greetings from #DisneylandParis - I hope for a French #biotech buyout soon 😉 Strong day for $ABVX 💪"
X Link 2025-12-09T22:23Z 5928 followers, 4053 engagements

"Good timing past week added @ $XXXX 🔥 $PALI now: $2.18"
X Link 2025-12-10T20:11Z 5928 followers, 2507 engagements

"$ZEAL outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health"
X Link 2025-12-11T07:08Z 5928 followers, 1001 engagements

"$ZEAL and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases"
X Link 2025-12-11T07:09Z 5928 followers, 1479 engagements

"$PTGX PN-477 is a really interesting peptide development candidate. If M&A: $JNJ would not only save the full control of Icotrokinra - they could also make a step into the #obesity market. $LLY $NVO $VKTX"
X Link 2025-12-11T21:19Z 5928 followers, 2585 engagements